Daily Archives: January 8, 2019

HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

PROVIDENCE, R.I., Jan. 08, 2019 (GLOBE NEWSWIRE) — Virgin Pulse, the largest global employee health and wellbeing company, today announced that renowned HR technology analyst and influencer Josh Bersin, has joined Virgin Pulse’s CEO Advisory Board.

DoubleVerify Partners with MoPub to Combat Mobile Ad Fraud

Partnership extends DV fraud coverage across MoPub’s mobile app exchange

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) — DoubleVerify (“DV”), the leading independent provider of marketing measurement software and analytics, today announced a partnership with MoPub, a leading provider of monetization solutions for mobile app publishers and developers around the globe.…

Quantenna’s Spartan Architecture Brings High-Capacity Mesh Wi-Fi to TIME’s Malaysian Customers

LAS VEGAS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Quantenna Communications, Inc. (NASDAQ : QTNA) announced today that Quantenna’s QV860 chipset is powering TIME dotCom’s latest dual-band dual concurrent mesh extender, the WiFi Booster.

Infovista names José Duarte as Chief Executive Officer

Newly appointed CEO to strengthen position for next stage of growth and scale

PARIS and ASHBURN, Va., Jan. 08, 2019 (GLOBE NEWSWIRE) — Infovista, the leader in modern network performance, today announced that its Board of Directors has appointed José Duarte as Chief Executive Officer effective immediately.

LeddarTech Joins Baidu’s Apollo Autonomous Driving Open Platform

LeddarTech joins Baidu’s Apollo autonomous driving open platform with its LiDAR products through an open source SDK

QUEBEC CITY, Jan. 08, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform, announced the integration of LeddarTech’s LiDAR products into Apollo, Baidu’s autonomous driving open platform.

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in

Non-Dystrophic Myotonic Disorders

Zug, Switzerland, 8 January 2019: Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders.

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

  • Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types – head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers – involving around 340 patients
  • Most of the trials are expected to be launched in 2019
  • Collaboration includes a $12M total investment from Nanobiotix

Paris, France, Cambridge, Massachusetts (USA) and Houston, Texas (USA), January 7 2019 – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers.…